News About: Goverment
Lee Sang-yong named deputy commissioner of KFDA
President Lee Myung-bak appointed on March 31 a former senior officer of Health and Welfare Ministry Lee Sang-yong, 54, as deputy commissioner of the Korea Food and Drug Administration.
Lee replaces Moon Byung-wo, ...
Government urged to evaluate patient's access
The Korean government needs to evaluate the effectiveness of new medicines in terms of patient's access, in addition to innovative concept and clinical significance, according to a report released by the Korea Institu...
KFDA warns methylphenidate abuse
The KFDA has issued a warning that methylphenidate may lead to an increase risk of psychiatric side effects as young students used to take this medicine frequently to boost their study achievements.
It instructed p...
Roche Korea file suit to nullify price reduction of Rocephin
Roche Korea says filed a lawsuit against the Ministry of Health, Welfare and Family Affairs to nullify the government's decision to lower the insurance price of Rocephin (ceftriaxone), a third-generation cephalosporin...
Health ministry unveils outcome-oriented welfare reforms
Vowing to set the basic format of a achievement-oriented social welfare reform, Minister of Health, Welfare and Family Affairs Kim Soung-yee announced his plans to carry out landmark reforms in the nation's health and...
Three pharmacists will likely be selected as legislators in April 9 election
The major parties unveiled the lineups of their proportional representation candidates on March 24. On its list, the governing Grand National Party (GNP) placed male pharmacist Won Hee-mok as its No. 16 proportional r...
Pfizer Korea hits government over drug pricing system
Pfizer Korea says it has filed to the Civil Rights Commission (CRC) an administrative suit against the Ministry of Health, Welfare and Family Affairs on March 10 for violating the patent rights under the new drug pric...
Insurance price of Sprycel to be determined in mid-April
The insurance coordination meeting aimed at determining the prices of Sprycel (dasatinib), BMS's leukemia medicine, will convene in the middle of next month, according to the Ministry of Health, Welfare and Family Aff...
Screening fees for application of new drugs to rise from June
The screening fees relating to application of new drugs will increase from this June, according to the Korea Food and Drug Administration.
Under the plan, the fees for the review of specification and analytical met...
Chong Kun Dang's Prigrel to benefit from health insurance
The Health Insurance Review & Assessment Service said on March 21 that two generic drugs of Plavix (clopidogrel bisulfate) Chong Kun Dang Pharmaceutical's Prigrel and Daewoong Pharm's Vixgrel - will be eligible for h...
